Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
21 studies found for:    (menopause OR postmenopause) [CONDITION ] ((hormone therapy) OR HRT) [TREATMENT ] | Open Studies
Show Display Options
Rank Status Study
1 Recruiting The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
Condition: Menopausal Syndromes
Interventions: Drug: Tibolone;   Drug: Estradiol & medroxyprogesterone acetate
2 Recruiting Efficacy Study of Progesterone Tablet in Post-menopausal Women
Condition: Menopause
Intervention: Drug: Progesterone
3 Recruiting Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure
Conditions: Breast Cancer;   Estrogen Receptor Positive Tumor;   Menopause;   Hormone Antagonist
Interventions: Drug: Immune-attractant;   Drug: Durvalumab;   Procedure: Biopsy
4 Recruiting Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
Condition: Menopause
Interventions: Drug: oral estradiol 0.5 mg;   Drug: oral estradiol 1.0 mg;   Drug: oral progesterone 100 mg
5 Not yet recruiting Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant
Condition: Breast Cancer
Interventions: Drug: alpelisib;   Drug: fulvestrant;   Drug: letrozole
6 Recruiting Females, Aging, Metabolism, and Exercise
Condition: Obesity
Interventions: Drug: GnRH agonist;   Behavioral: Supervised cardiovascular exercise;   Drug: Placebo
7 Recruiting Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Conditions: Cognitive Impairment;   Executive Dysfunction;   Endothelial Dysfunction;   Cardiovascular Disease
Interventions: Drug: Leuprolide acetate;   Drug: Estradiol;   Drug: Medroxyprogesterone;   Drug: Placebo
8 Recruiting Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
Conditions: Atrophic Vaginitis;   Menopause
Interventions: Device: CO2 fractionated vaginal laser;   Drug: Estrogens, Conjugated (USP)
9 Not yet recruiting Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
Conditions: Primary Ovarian Insufficiency;   Menopause, Premature
Intervention: Drug: Drospirenone and ethinyl estradiol combination (Yasmin)
10 Recruiting PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Diagnostic Imaging: 18F-FDG PET/CT Scan - Baseline;   Procedure: Diagnostic Imaging: 18F-FES PET/CT - Baseline;   Procedure: Diagnostic Imaging: 18F-FES PET/CT - 3 month follow-up
11 Not yet recruiting Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women
Conditions: Atrophy of Vagina;   Postmenopause
Intervention: Drug: Gynoflor
12 Not yet recruiting Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects
Condition: Menopause
Interventions: Drug: Estrogens;   Other: Placebo
13 Recruiting Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
Conditions: Atrophic Vaginitis;   Menopause;   Vulvovaginal Atrophy
Interventions: Drug: Vaginal progesterone;   Drug: Placebo
14 Recruiting Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial
Conditions: Cerebral Aneurysm;   Menopause;   Treatment
Interventions: Drug: Estradiol;   Drug: Placebo
15 Recruiting Transdermal Testosterone Nanoemulsion in Women Libido
Condition: Menopause
Interventions: Drug: Testosterone;   Drug: Placebo
16 Recruiting Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
Conditions: Estrogen;   Menopause;   Pelvic Floor Disorders;   Surgery
Interventions: Drug: Premarin;   Drug: Vagifem
17 Recruiting Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression
Condition: Menopausal Depression
Intervention: Drug: Tibolone
18 Not yet recruiting Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%
Condition: Post-menopausal Period
Interventions: Drug: Testosterone gel 1% 2.2 mg;   Drug: Testosterone gel 1% 4.4 mg;   Drug: Testosterone gel 1% 8.8 mg;   Drug: Placebo of Testosterone Gel 1%
19 Recruiting Assessing Fertility Potential in Female Cancer Survivors
Condition: Effects of Chemotherapy
Intervention:
20 Recruiting Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction
Condition: Sexual Dysfunction, Physiological
Interventions: Drug: Ospemifene;   Drug: Vaginal conjugated estrogens

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.